Form 8-K - Current report:
SEC Accession No. 0001193125-25-031354
Filing Date
2025-02-21
Accepted
2025-02-21 08:21:24
Documents
16
Period of Report
2025-02-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d885218d8k.htm   iXBRL 8-K 58309
2 EX-2.1 d885218dex21.htm EX-2.1 702142
3 EX-10.1 d885218dex101.htm EX-10.1 47538
4 EX-99.1 d885218dex991.htm EX-99.1 21763
  Complete submission text file 0001193125-25-031354.txt   1157105

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA blue-20250221.xsd EX-101.SCH 2862
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE blue-20250221_lab.xml EX-101.LAB 17235
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE blue-20250221_pre.xml EX-101.PRE 10820
18 EXTRACTED XBRL INSTANCE DOCUMENT d885218d8k_htm.xml XML 3503
Mailing Address 455 GRAND UNION BOULEVARD SOMERVILLE MA 02145
Business Address 455 GRAND UNION BOULEVARD SOMERVILLE MA 02145 339-499-9300
bluebird bio, Inc. (Filer) CIK: 0001293971 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35966 | Film No.: 25648536
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)